The COVID-19 pandemic has created excruciating burden for the healthcare sector. Dhiti Omics Technologies is happy to announce the launch of RT-PCR based COVID19 testing from its’ state of the art NABL accredited and ICMR approved PCR labs.
Our high-throughput COVID-19 testing facility is equipped to handle regular and surge capacity testing. We shall test at scale to assist hospitals, clinics, and nursing homes; high impact communities; educational institutions; and individuals.
We are ICMR approved and NABL accredited to offer a qualitative 3 gene RT-PCR assay for testing of SARS-CoV-2. The performance of this test has been established using nasopharyngeal swab and oropharyngeal swab samples. Bronchoalveolar lavage and other swabs (mid-turbinate and anterior nasal)/washes/aspirates are also considered acceptable specimen types, although the performance has not been established. The testing is offered with a turnaround time [TAT] of 24-48 hours.
Other tests available for Covid-19
Rapid Antigen testing (RAT) ‐ On site testing with Rapid Antigen kit using ICMR, CE and WHO approved lateral flow assays performed with immediate reporting.
TataMD CHECK ‐ Based on FELUDA CRISPR Cas-9 genomic technology, TataMD CHECK is an ICMR-approved and DCGI-certified, COVID-19 viral detection test with a sensitivity and specificity that is at par with qPCR.
Pooled testing ‐ For campus screening/safety of workplaces, a screening program that offers the highest throughput and lowest cost per sample without compromising on sensitivity. Based on Mathematical pooling called Tapestry developed by Algorthmic Biologics, several campuses are now safe for students. Samples are collected on campus, pooled testing is done by RT-PCR and results returned the same day.